Citations (53)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (3)
Yu Dong, Tao Xu, Dongfan Li, Hua Guo, Xusheng Du, Guangshun Li, Jiakuan Chen, Bo Wang, Peng Wang, Gang Yu, Xuan Zhao & Ruiqi Xue. (2022) NLR family CARD domain containing 5 promotes hypoxia-induced cancer progress and carboplatin resistance by activating PI3K/AKT via carcinoembryonic antigen related cell adhesion molecule 1 in non-small cell lung cancer. Bioengineered 13:6, pages 14413-14425.
Read now
Read now
Karthikeyan Subbarayan, Sandra Leisz, Claudia Wickenhauser, Daniel Bethmann, Chiara Massa, André Steven & Barbara Seliger. (2018) Biglycan-mediated upregulation of MHC class I expression in HER-2/neu-transformed cells. OncoImmunology 7:4.
Read now
Read now
Komal Dolasia, Manoj K Bisht, Gourango Pradhan, Atul Udgata & Sangita Mukhopadhyay. (2018) TLRs/NLRs: Shaping the landscape of host immunity. International Reviews of Immunology 37:1, pages 3-19.
Read now
Read now
Articles from other publishers (50)
Marta Canel, Aleksandra Dominika Sławińska, David W Lonergan, Ashwin Adrian Kallor, Rosie Upstill-Goddard, Catherine Davidson, Alex von Kriegsheim, Andrew V Biankin, Adam Byron, Javier Alfaro & Alan Serrels. (2024) FAK suppresses antigen processing and presentation to promote immune evasion in pancreatic cancer. Gut 73:1, pages 131-155.
Crossref
Crossref
Lu Wang, Tianyu Zhang, Yile Zheng, Yuting Li, Xiyuan Tang, Qianping Chen, Wei Mao, Weiwei Li, Xiangsheng Liu & Ji Zhu. (2023) Combination of irinotecan silicasome nanoparticles with radiation therapy sensitizes immunotherapy by modulating the activation of the cGAS/STING pathway for colorectal cancer. Materials Today Bio 23, pages 100809.
Crossref
Crossref
Mi-Heon Lee, Duang Ratanachan, Zitian Wang, Jacob Hack, Lobna Adbulrahman, Nicholas P. Shamlin, Mirna Kalayjian, Jean Philippe Nesseler, Ekambaram Ganapathy, Christine Nguyen, Josephine A. Ratikan, Nicolas A. Cacalano, David Austin, Robert Damoiseaux, Benjamin J. DiPardo, Danielle S. Graham, Anusha Kalbasi, James W. Sayre, William H. McBride & Dörthe Schaue. (2023) Adaptation of the Tumor Antigen Presentation Machinery to Ionizing Radiation. The Journal of Immunology 211:4, pages 693-705.
Crossref
Crossref
Minting Wen, Yingjing Li, Xiaonan Qin, Bing Qin & Qiong Wang. (2023) Insight into Cancer Immunity: MHCs, Immune Cells and Commensal Microbiota. Cells 12:14, pages 1882.
Crossref
Crossref
Sarah Bauer, Lucy Hezinger, Fjolla Rexhepi, Sheela Ramanathan & Thomas A. Kufer. (2023) NOD-like Receptors—Emerging Links to Obesity and Associated Morbidities. International Journal of Molecular Sciences 24:10, pages 8595.
Crossref
Crossref
Uxia Gestal‐Mato & Lina Herhaus. (2023) Autophagy‐dependent regulation of MHC‐I molecule presentation. Journal of Cellular Biochemistry.
Crossref
Crossref
Madanraj Appiya Santharam, Akhil Shukla, Dominique Levesque, Thomas A. Kufer, François-Michel Boisvert, Sheela Ramanathan & Subburaj Ilangumaran. (2023) NLRC5-CIITA Fusion Protein as an Effective Inducer of MHC-I Expression and Antitumor Immunity. International Journal of Molecular Sciences 24:8, pages 7206.
Crossref
Crossref
Akouavi Julite Irmine Quenum, Madanraj Appiya Santharam, Sheela Ramanathan & Subburaj Ilangumaran. (2022) Inflammatory Cytokines That Enhance Antigen Responsiveness of Naïve CD8+ T Lymphocytes Modulate Chromatin Accessibility of Genes Impacted by Antigen Stimulation. International Journal of Molecular Sciences 23:22, pages 14122.
Crossref
Crossref
Li Tengda, Qian Cheng & Sun Yi. (2022) Identification of Melanoma Subsets Based on DNA Methylation Sites and Construction of a Prognosis Evaluation Model. Journal of Oncology 2022, pages 1-15.
Crossref
Crossref
Peter A. Fasching, Duan Liu, Steve Scully, James N. Ingle, Paulo C. LyraJr.Jr., Brigitte Rack, Alexander Hein, Arif B. Ekici, Andre Reis, Andreas Schneeweiss, Hans Tesch, Tanja N. Fehm, Georg Heinrich, Matthias W. Beckmann, Matthias Ruebner, Hanna Huebner, Diether Lambrechts, Ebony Madden, Jess Shen, Jane Romm, Kim Doheny, Gregory D. Jenkins, Erin E. Carlson, Liang Li, Brooke L. Fridley, Julie M. Cunningham, Wolfgang Janni, Alvaro N.A. Monteiro, Daniel J. Schaid, Lothar Häberle, Richard M. Weinshilboum & Liewei Wang. (2022) Identification of Two Genetic Loci Associated with Leukopenia after Chemotherapy in Patients with Breast Cancer. Clinical Cancer Research 28:15, pages 3342-3355.
Crossref
Crossref
Eugenio Jara, Francisco Peñagaricano, Eileen Armstrong, Gabriel Ciappesoni, Andrés Iriarte & Elly Ana Navajas. (2022) Revealing the genetic basis of eyelid pigmentation in Hereford cattle. Journal of Animal Science 100:5.
Crossref
Crossref
Lei Zhan, Junhui Zhang, Jing Zhang, Xiaojing Liu, Suding Zhu, Yuchuan Shi, Yu He, Wenyan Wang, Yijun Fan, Zhenhai Tang, Guo Chen, Bing Wei & Yunxia Cao. (2022) LC3 and NLRC5 interaction inhibits NLRC5-mediated MHC class I antigen presentation pathway in endometrial cancer. Cancer Letters 529, pages 37-52.
Crossref
Crossref
Su-ding Zhu, Jing Zhang, Xiao-jing Liu, Jun-hui Zhang, Bing Wei, Wen-yan Wang, Yi-jun Fan, Dan Li, Yun-xia Cao & Lei Zhan. (2022) NLRC5 Might Promote Endometrial Cancer Progression by Inducing PD-L1 Expression. Technology in Cancer Research & Treatment 21, pages 153303382211127.
Crossref
Crossref
Abdulkareem Olarewaju Babamale & Szu-Ting Chen. (2021) Nod-like Receptors: Critical Intracellular Sensors for Host Protection and Cell Death in Microbial and Parasitic Infections. International Journal of Molecular Sciences 22:21, pages 11398.
Crossref
Crossref
Chrissie E. B. Ong, Amanda L. Patchett, Jocelyn M. Darby, Jinying Chen, Guei-Sheung Liu, A. Bruce Lyons, Gregory M. Woods & Andrew S. Flies. (2021) NLRC5 regulates expression of MHC-I and provides a target for anti-tumor immunity in transmissible cancers. Journal of Cancer Research and Clinical Oncology 147:7, pages 1973-1991.
Crossref
Crossref
Steven X. Cho, Saptha Vijayan, Ji‐Seung Yoo, Toshiyuki Watanabe, Ryota Ouda, Ning An & Koichi S. Kobayashi. (2020) MHC class I transactivator NLRC5 in host immunity, cancer and beyond. Immunology 162:3, pages 252-261.
Crossref
Crossref
Per Anderson, Natalia Aptsiauri, Francisco Ruiz-Cabello & Federico Garrido. (2021) HLA class I loss in colorectal cancer: implications for immune escape and immunotherapy. Cellular & Molecular Immunology 18:3, pages 556-565.
Crossref
Crossref
Nicholas B. Blackburn, Ana Cristina Leandro, Nina Nahvi, Mariana A. Devlin, Marcelo Leandro, Ignacio Martinez Escobedo, Juan M. Peralta, Jeff George, Brian A. Stacy, Thomas W. deMaar, John Blangero, Megan Keniry & Joanne E. Curran. (2021) Transcriptomic Profiling of Fibropapillomatosis in Green Sea Turtles (Chelonia mydas) From South Texas. Frontiers in Immunology 12.
Crossref
Crossref
Akhil Shukla, Maryse Cloutier, Madanraj Appiya Santharam, Sheela Ramanathan & Subburaj Ilangumaran. (2021) The MHC Class-I Transactivator NLRC5: Implications to Cancer Immunology and Potential Applications to Cancer Immunotherapy. International Journal of Molecular Sciences 22:4, pages 1964.
Crossref
Crossref
Sayuri Yoshihama, Steven X. Cho, Jason Yeung, Xuedong Pan, Gregory Lizee, Kranti Konganti, Valen E. Johnson & Koichi S. Kobayashi. (2021) NLRC5/CITA expression correlates with efficient response to checkpoint blockade immunotherapy. Scientific Reports 11:1.
Crossref
Crossref
Jorge Alfonso León Machado & Viktor Steimle. (2021) The MHC Class II Transactivator CIITA: Not (Quite) the Odd-One-Out Anymore among NLR Proteins. International Journal of Molecular Sciences 22:3, pages 1074.
Crossref
Crossref
Hátylas Azevedo, Guilherme Cavalcante Pessoa, Francisca Nathália de Luna Vitorino, Jérémie Nsengimana, Julia Newton-Bishop, Eduardo Moraes Reis, Júlia Pinheiro Chagas da Cunha & Miriam Galvonas Jasiulionis. (2020) Gene co-expression and histone modification signatures are associated with melanoma progression, epithelial-to-mesenchymal transition, and metastasis. Clinical Epigenetics 12:1.
Crossref
Crossref
Jay Gunawardana, Justina N. Lee, Karolina Bednarska, Valentine Murigneux, Lilia Merida Long, Muhammed B. Sabdia, Simone Birch, Joshua W. D. Tobin & Maher K. Gandhi. (2020)
Genetic aberrations of
NLRC5
are associated with downregulated MHC‐I antigen presentation and impaired T‐cell immunity in follicular lymphoma
. eJHaem 1:2, pages 517-526.
Crossref
Crossref
Anusha Kalbasi, Mito Tariveranmoshabad, Kevin Hakimi, Sarah Kremer, Katie M. CampbellJuan M. FunesAgustin Vega-CrespoGiulia Parisi, Ameya ChampekarChristine Nguyen, Davis Torrejon, Daniel Shin, Jesse M. Zaretsky, Robert D. DamoiseauxDaniel E. Speiser, Pedro P. Lopez-Casas, Marisol Quintero & Antoni Ribas. (2020) Uncoupling interferon signaling and antigen presentation to overcome immunotherapy resistance due to JAK1 loss in melanoma. Science Translational Medicine 12:565.
Crossref
Crossref
Agnieszka Kula, Miriam Dawidowicz, Paweł Kiczmer, Alicja Prawdzic Seńkowska & Elżbieta Świętochowska. (2020) The role of genetic polymorphism within PD-L1 gene in cancer. Review. Experimental and Molecular Pathology 116, pages 104494.
Crossref
Crossref
Laura Fahey, Gary Donohoe, Pilib Ó. Broin & Derek W. Morris. (2020)
Genes regulated by
BCL11B
during T‐cell development are enriched for de novo mutations found in schizophrenia patients
. American Journal of Medical Genetics Part B: Neuropsychiatric Genetics 183:6, pages 370-379.
Crossref
Crossref
Hyungsoo Kim, Heejung KimYongmei FengYan LiHironari Tamiya, Stefania TocciZe’ev A. Ronai. (2020) PRMT5 control of cGAS/STING and NLRC5 pathways defines melanoma response to antitumor immunity. Science Translational Medicine 12:551.
Crossref
Crossref
Annelisa M. Cornel, Iris L. Mimpen & Stefan Nierkens. (2020) MHC Class I Downregulation in Cancer: Underlying Mechanisms and Potential Targets for Cancer Immunotherapy. Cancers 12:7, pages 1760.
Crossref
Crossref
Ya-Ru Ji, Yu Chen, Yan-Ni Chen, Gao-Lin Qiu, Jia-Gen Wen, Yan Zheng, Xiao-Feng Li, Huang Cheng, Yuan-Hai Li & Jun Li. (2020) Dexmedetomidine inhibits the invasion, migration, and inflammation of rheumatoid arthritis fibroblast-like synoviocytes by reducing the expression of NLRC5. International Immunopharmacology 82, pages 106374.
Crossref
Crossref
Lauren K. Zebertavage, Alejandro Alice, Marka R. Crittenden & Michael J. Gough. (2020) Transcriptional Upregulation of NLRC5 by Radiation Drives STING- and Interferon-Independent MHC-I Expression on Cancer Cells and T Cell Cytotoxicity. Scientific Reports 10:1.
Crossref
Crossref
Feng Tang, Yadi Xu & Bing Zhao. (2020) NLRC5: new cancer buster?. Molecular Biology Reports 47:3, pages 2265-2277.
Crossref
Crossref
Barbara Seliger & Soldano Ferrone. 2020. Biomarkers for Immunotherapy of Cancer. Biomarkers for Immunotherapy of Cancer
325
350
.
Jie-quan Wang, Ya-ru Liu, Quan Xia, Ruo-nan Chen, Jun Liang, Qing-rong Xia & Jun Li. (2019) Emerging Roles for NLRC5 in Immune Diseases. Frontiers in Pharmacology 10.
Crossref
Crossref
Peng Liu, Ziwen Lu, Lanlan Liu, Ruyan Li, Zhiquan Liang, Mingxiang Shen, Han Xu, Dewan Ren, Mengchen Ji, Sirui Yuan, Dongsheng Shang, Yibang Zhang, Hanqing Liu & Zhigang Tu. (2019) NOD-like receptor signaling in inflammation-associated cancers: From functions to targeted therapies. Phytomedicine 64, pages 152925.
Crossref
Crossref
Muzi Wang, Lixia Wang, Lei Fang, Shuai Li & Rongyu Liu. (2019) NLRC5 negatively regulates LTA‐induced inflammation via TLR2/NF‐κB and participates in TLR2‐mediated allergic airway inflammation. Journal of Cellular Physiology 234:11, pages 19990-20001.
Crossref
Crossref
Marlieke L.M. Jongsma, Greta Guarda & Robbert M. Spaapen. (2019) The regulatory network behind MHC class I expression. Molecular Immunology 113, pages 16-21.
Crossref
Crossref
Zheqi Zong, Yichen Song, Yixue Xue, Xuelei Ruan, Xiaobai Liu, Chunqing Yang, Jian Zheng, Shuo Cao, Zhen Li & Yunhui Liu. (2019) Knockdown of LncRNA SCAMP1 suppressed malignant biological behaviours of glioma cells via modulating miR‐499a‐5p/LMX1A/NLRC5 pathway. Journal of Cellular and Molecular Medicine 23:8, pages 5048-5062.
Crossref
Crossref
Tian Sun, Richard L Ferrero, Stephen E Girardin, Jennifer L Gommerman & Dana J Philpott. (2019)
NLRC5 deficiency has a moderate impact on immunodominant
CD
8
+
T‐cell responses during rotavirus infection of adult mice
. Immunology & Cell Biology 97:6, pages 552-562.
Crossref
Crossref
Peipei Luan, Weixia Jian, Xu Xu, Wenxin Kou, Qing Yu, Handan Hu, Dali Li, Wei Wang, Mark W. Feinberg, Jianhui Zhuang, Yawei Xu & Wenhui Peng. (2019) NLRC5 inhibits neointima formation following vascular injury and directly interacts with PPARγ. Nature Communications 10:1.
Crossref
Crossref
Yuting Wu, Tianlu Shi & Jun Li. (2019) NLRC5: A paradigm for NLRs in immunological and inflammatory reaction. Cancer Letters 451, pages 92-99.
Crossref
Crossref
Qin Wang, Handong Ding, Yinghua He, Xiaofeng Li, Yahui Cheng, Qingqing Xu, Yue Yang, Guiyi Liao, Xiaoming Meng, Cheng Huang & Jun Li. (2019) NLRC5 mediates cell proliferation, migration, and invasion by regulating the Wnt/β-catenin signalling pathway in clear cell renal cell carcinoma. Cancer Letters 444, pages 9-19.
Crossref
Crossref
Saptha Vijayan, Tabasum Sidiq, Suhail Yousuf, Peter J. van den Elsen & Koichi S. Kobayashi. (2019) Class I transactivator, NLRC5: a central player in the MHC class I pathway and cancer immune surveillance. Immunogenetics 71:3, pages 273-282.
Crossref
Crossref
Qian Zeng, Xiaoping Chen, Chaoxue Ning, Qiao Zhu, Yao Yao, Yali Zhao & Fuxin Luan. (2018) Methylation of the genes ROD1, NLRC5, and HKR1 is associated with aging in Hainan centenarians. BMC Medical Genomics 11:1.
Crossref
Crossref
Yuemei Li, Min Zhang & Xinhua Zheng. (2018) High Expression of NLRC5 is associated with prognosis of gastric cancer. Open Medicine 13:1, pages 443-449.
Crossref
Crossref
V Mett, E A Komarova, K Greene, I Bespalov, C Brackett, B Gillard, A S Gleiberman, I A Toshkov, S Aygün-Sunar, C Johnson, E Karasik, M Bapardekar-Nair, O V Kurnasov, A L Osterman, P S Stanhope-Baker, C Morrison, M T Moser, B A Foster & A V Gudkov. (2017) Mobilan: a recombinant adenovirus carrying Toll-like receptor 5 self-activating cassette for cancer immunotherapy. Oncogene 37:4, pages 439-449.
Crossref
Crossref
Ya-ru Liu, Xing Yan, Hai-xia Yu, Yao Yao, Jie-quan Wang, Xiao-feng Li, Ruo-nan Chen, Qing-qing Xu, Tao-tao Ma, Cheng Huang & Jun Li. (2017) NLRC5 promotes cell proliferation via regulating the NF-κB signaling pathway in Rheumatoid arthritis. Molecular Immunology 91, pages 24-34.
Crossref
Crossref
Szilvia Benkő, Elek Gergő Kovács, Felix Hezel & Thomas A. Kufer. (2017) NLRC5 Functions beyond MHC I Regulation—What Do We Know So Far?. Frontiers in Immunology 8.
Crossref
Crossref
Sayuri Yoshihama, Saptha Vijayan, Tabasum Sidiq & Koichi S. Kobayashi. (2017) NLRC5/CITA: A Key Player in Cancer Immune Surveillance. Trends in Cancer 3:1, pages 28-38.
Crossref
Crossref
S.T. Chelbi, A.T. Dang & G. Guarda. 2017.
89
119
.
Sonia T. Chelbi & Greta Guarda. (2016) NLRC5, a promising new entry in tumor immunology. Journal for ImmunoTherapy of Cancer 4:1.
Crossref
Crossref